Social & Political Sciences
Global

Social & Political Sciences Experts

Lance Smith

Associate Professor
Department of Leadership and Developmental Sciences
University of Vermont
United States of America

Biography

Dr. Lance Smith is currently working as a Associate Professor in the Department of Department of Leadership and Developmental Sciences, , United States of America. His research interests includes Clinical Supervision; Diversity, Access, and Equity; Human Development and Identity; Mental Health; Multiculturalism; Race and Racism; Research Methods; School Counseling; Social Justice. He /she is serving as an editorial member and reviewer of several international reputed journals. Dr. Lance Smith is the member of many international affiliations. He/ She has successfully completed his Administrative responsibilities. He /she has authored of many research articles/books related to Clinical Supervision; Diversity, Access, and Equity; Human Development and Identity; Mental Health; Multiculturalism; Race and Racism; Research Methods; School Counseling; Social Justice.

Research Interest

Clinical Supervision; Diversity, Access, and Equity; Human Development and Identity; Mental Health; Multiculturalism; Race and Racism; Research Methods; School Counseling; Social Justice

Publications

  • Smith LA, Jackson MJ, Al‐Barghouthy G, Rose S, Kuoppamaki M, Olanow W, Jenner P. Multiple small doses of levodopa plus entacapone produce continuous dopaminergic stimulation and reduce dyskinesia induction in MPTP‐treated drug‐naive primates. Movement disorders. 2005 Mar 1;20(3):306-14.

  • Kanda T, Jackson MJ, Smith LA, Pearce RK, Nakamura J, Kase H, Kuwana Y, Jenner P. Combined use of the adenosine A 2A antagonist KW-6002 with L-DOPA or with selective D1 or D2 dopamine agonists increases antiparkinsonian activity but not dyskinesia in MPTP-treated monkeys. Experimental neurology. 2000 Apr 30;162(2):321-7.

  • Kanda T, Jackson MJ, Smith LA, Pearce RK, Nakamura J, Kase H, Kuwana Y, Jenner P. Adenosine A2A antagonist: a novel antiparkinsonian agent that does not provoke dyskinesia in parkinsonian monkeys. Annals of neurology. 1998 Apr 1;43(4):507-13.

Global Experts from United States of America

Global Experts in Subject